Cleveland Clinic Cancer Center (Taussig) Outcomes
Renal Cell Cancer
Renal Cell Cancer
Five-Year Overall Survival of Patients With All Stages of Renal Cell Cancer (N = 4284)
2009-2019
ᵃNational comparison represents survival after diagnosis from Stat Facts: An interactive tool for access to Surveillance, Epidemiology, and End Results (SEER) cancer statistics. Surveillance Research Program, National Cancer Institute. https://seer.cancer.gov/statfacts/html/kidrp.html. Accessed July 1, 2020.
Five-Year Overall Survival of Patients With Renal Cell Cancer by Stageᵃ at Diagnosis (N = 3946)
2009-2019
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year |
|---|---|---|---|---|---|
| Stage I (N = 2294) | 1984 | 1680 | 1322 | 984 | 624 |
| Stage II (N = 177) | 153 | 124 | 95 | 64 | 49 |
| Stage III (N = 947) | 754 | 604 | 428 | 335 | 210 |
| Stage IV (N = 528) | 269 | 162 | 102 | 71 | 34 |
CC = Cleveland Clinic
ᵃ American Joint Committee on Cancer (AJCC) stage 0-V renal cell carcinoma
